Literature DB >> 17888603

[A severe form of Chryseobacterium indologenes pneumonia in an immunocompetent patient].

I Reynaud1, V Chanteperdrix, C Broux, P Pavese, J Croizé, M Maurin, J-P Stahl, C Jacquot.   

Abstract

We report a case of severe pneumonia due to Chryseobacterium indologenes in an immunocompetent patient. Chryseobacterium indologenes (formerly Flavobacterium indologenes) are saprophytic Gram-negative rods widely distributed in damp environment. Many sites of infection were described in the literature. These infections are always severe sometimes associated to multiple organ failure. The evolution is usually favorable with antibiotic treatment. Bacteria characteristically grow as yellow-pigmented colonies. They are naturally resistant to many antimicrobial agents. They are usually susceptible to piperacillin(DCI) alone or combined with tazobactam(DCI), ceftazidime(DCI), cefepime(DCI), fluoroquinolones(DCI), rifampin(DCI) and cotrimoxazole(DCI), but the in vitro susceptibility to these antibiotics should be systematically tested. Nevertheless, the optimum antibiotic treatment for Chryseobacterium-related infections remains to be established. In the case we report, the diagnosis was made according to the results of bronchial sample bacterial culture. This case report underlines the need for specific management of patients infected with this species.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17888603     DOI: 10.1016/j.medmal.2007.01.006

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  9 in total

1.  Chryseobacterium septicemia in a renal allograft recipient.

Authors:  Ankur Gupta; Ambar Khaira; Ashwini Gupta; Anil K Bhalla; Devender S Rana
Journal:  Clin Exp Nephrol       Date:  2009-09-29       Impact factor: 2.801

2.  Severe sepsis due to Chryseobacterium indologenes in an immunocompetent adventure traveler.

Authors:  Genevieve McKew
Journal:  J Clin Microbiol       Date:  2014-08-27       Impact factor: 5.948

3.  Whole-genome sequence of Chryseobacterium oranimense, a colistin-resistant bacterium isolated from a cystic fibrosis patient in France.

Authors:  Poonam Sharma; Sushim Kumar Gupta; Seydina M Diene; Jean-Marc Rolain
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

4.  Characterization of CIA-1, an Ambler class A extended-spectrum β-lactamase from Chryseobacterium indologenes.

Authors:  Takehisa Matsumoto; Mika Nagata; Nau Ishimine; Kenji Kawasaki; Kazuyoshi Yamauchi; Eiko Hidaka; Eriko Kasuga; Kazuki Horiuchi; Kozue Oana; Yoshiyuki Kawakami; Takayuki Honda
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

5.  Chryseobacterium tagetis sp. nov., a plant growth promoting bacterium with an antimicrobial activity isolated from the roots of medicinal plant (Tagetes patula).

Authors:  Geeta Chhetri; Inhyup Kim; Jiyoun Kim; Yoonseop So; Taegun Seo
Journal:  J Antibiot (Tokyo)       Date:  2022-04-19       Impact factor: 3.424

6.  IND-6, a highly divergent IND-type metallo-beta-lactamase from Chryseobacterium indologenes strain 597 isolated in Burkina Faso.

Authors:  Boukaré Zeba; Filomena De Luca; Alain Dubus; Michael Delmarcelle; Jacques Simporé; Odile G Nacoulma; Gian Maria Rossolini; Jean-Marie Frère; Jean-Denis Docquier
Journal:  Antimicrob Agents Chemother       Date:  2009-08-03       Impact factor: 5.191

7.  Profile and multidrug resistance determinants of Chryseobacterium indologenes from seawater and marine fauna.

Authors:  Ana Maravić; Mirjana Skočibušić; Ivica Samanić; Jasna Puizina
Journal:  World J Microbiol Biotechnol       Date:  2012-11-07       Impact factor: 3.312

8.  Pleural effusion due to Chryseobacterium indologenes: Case report and review of literature.

Authors:  Nazneen Arif; Swati Khullar; Ratnesh Kumar; Shiv Kumar Choudhary; Arti Kapil; Benu Dhawan
Journal:  J Lab Physicians       Date:  2019 Jul-Sep

9.  Characterization and Comparative Genomic Analysis of a Highly Colistin-Resistant Chryseobacterium gallinarum: a Rare, Uncommon Pathogen.

Authors:  Mahendra Gaur; Suchanda Dey; Anshuman Sahu; Sangita Dixit; S Sarathbabu; John Zothanzama; Rajesh Kumar Sahoo; Dibyajyoti Uttameswar Behera; Enketeswara Subudhi
Journal:  Front Cell Infect Microbiol       Date:  2022-07-14       Impact factor: 6.073

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.